XML 48 R38.htm IDEA: XBRL DOCUMENT v3.24.3
STOCK BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Weighted Average Inputs and Assumptions

   September 30,   September 30, 
   2024   2023 
Grant date stock price and exercise price  $   $12.03 
Dividend yield       2.89%
Expected stock price volatility       23.37%
Risk-free interest rate       3.50%
Expected option life in years       6 
           
Total weighted-average fair value of options granted  $   $2.42 
Schedule of Stock Option Activity

A summary of stock option activity for the first nine months of 2024 is presented below (Aggregate Intrinsic Value in thousands):

   Shares
Subject to
Options
   Weighted-
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual
Term
   Aggregate
Intrinsic
Value
 
Outstanding at beginning of year   137,500   $13.86    2.1 years      
Granted                
Exercised                
Forfeited or expired   (25,000)   14.90    0.7 years      
Outstanding on September 30, 2024   112,500   $13.63    0.7 years   $33 
                     
Exercisable on September 30, 2024   106,300   $13.63    0.6 years   $33 
Schedule of Non-Vested Restricted Stock Activity

   Shares   Weighted-
Average
Grant
Date Fair
Value
   Average
Remaining
Contractual
Term
 
Non-vested on January 1, 2024   13,400   $12.97    3.9 years 
Granted            
Vested   (8,700)   13.00    0.7 years 
Forfeited            
Non-vested on September 30, 2024   4,700   $12.91    3.1 years 
Schedule of Unrecognized Equity-Based Expense under 2017 Equity Incentive Plan

Year    
2024  $5 
2025   21 
2026   21 
2027   13 
2028   3 
Totals  $63